Janux Therapeutics, Inc.
JANX
$26.99
-$1.26-4.46%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/3/2025
-
Tickeron - Stocks
4/3/2025
-
Tickeron - Stocks
4/2/2025
-
Ticker Report
4/2/2025
-
Tickeron - Stocks
4/2/2025
-
Tickeron - Stocks
4/2/2025
-
MarketBeat
4/1/2025
-
MarketBeat
4/1/2025
-
Tickeron - Stocks
4/1/2025
-
Tickeron - Stocks
3/31/2025
-
Ticker Report
3/31/2025
-
MarketBeat
3/29/2025
-
MarketBeat
3/28/2025
-
Yahoo! Finance: News
3/27/2025
-
Tickeron - Stocks
3/27/2025
-
Insider Monkey
3/26/2025
-
Insider Monkey
3/26/2025
-
24/7 Wall St.
3/25/2025
-
Tickeron - Stocks
3/24/2025
-
Insider Monkey
3/23/2025
-
MarketBeat
3/21/2025
-
GuruFocus
3/21/2025
-
Tickeron - Stocks
3/21/2025
-
MarketBeat
3/21/2025
-
MarketBeat
3/20/2025
-
Insider Monkey
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 751 4493
Address
10955 Vista Sorrento Parkway
San Diego, CA 92130
San Diego, CA 92130
Country
Year Founded
Business Description
Sector
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr)...
more
